Clinical Subgroups in Bilateral Meniere Disease

Autor: Frejo, L, Soto-Varela, A, Santos-Perez, S, Aran, I, Batuecas-Caletrio, A, Perez-Guillen, V, Perez-Garrigues, H, Fraile, J, Martin-Sanz, E, Tapia, MC, Trinidad, G, Garcia-Arumi, AM, Gonzalez-Aguado, R, Espinosa-Sanchez, JM, Marques, P, Perez, P, Benitez, J, Lopez-Escamez, JA, Menieres Dis Consortium MeDiC

Publikováno v: Frontiers in neurology
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Meniere disease (MD) is a heterogeneous clinical condition characterized by sensorineural hearing loss, episodic vestibular symptoms, and tinnitus associated with several comorbidities, such as migraine or autoimmune disorders (AD). The frequency of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::56ae4518eeecdbfb804d74100867864d
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=9082

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

H3K9 dimethylation safeguards cancer cells against activation of the interferon pathway.

Autor: Hansen AM; The Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.; Biotech Research and Innovation Center (BRIC), University of Copenhagen, 2200 Copenhagen, Denmark.; Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark., Ge Y; The Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.; Biotech Research and Innovation Center (BRIC), University of Copenhagen, 2200 Copenhagen, Denmark.; Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark., Schuster MB; The Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.; Biotech Research and Innovation Center (BRIC), University of Copenhagen, 2200 Copenhagen, Denmark.; Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark., Pundhir S; The Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.; Biotech Research and Innovation Center (BRIC), University of Copenhagen, 2200 Copenhagen, Denmark.; Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark., Jakobsen JS; The Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.; Biotech Research and Innovation Center (BRIC), University of Copenhagen, 2200 Copenhagen, Denmark.; Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark., Kalvisa A; The Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.; Biotech Research and Innovation Center (BRIC), University of Copenhagen, 2200 Copenhagen, Denmark.; Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark., Tapia MC; The Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.; Biotech Research and Innovation Center (BRIC), University of Copenhagen, 2200 Copenhagen, Denmark.; Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark., Gordon S; Biotech Research and Innovation Center (BRIC), University of Copenhagen, 2200 Copenhagen, Denmark.; Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark., Ambri F; Biotech Research and Innovation Center (BRIC), University of Copenhagen, 2200 Copenhagen, Denmark.; Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark., Bagger FO; The Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.; Biotech Research and Innovation Center (BRIC), University of Copenhagen, 2200 Copenhagen, Denmark.; Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.; Center for Genomic Medicine, Copenhagen University Hospital, Copenhagen, Denmark., Pandey D; Biotech Research and Innovation Center (BRIC), University of Copenhagen, 2200 Copenhagen, Denmark.; Department of Microbiology, Oslo University Hospital, NO-0373 Oslo, Norway., Helin K; Biotech Research and Innovation Center (BRIC), University of Copenhagen, 2200 Copenhagen, Denmark.; Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.; Cell Biology Program and Center for Epigenetics Research, Memorial Sloan Kettering Center, New York, NY 10065, USA.; The Institute of Cancer Research, London SW3 6JB, United Kingdom., Porse BT; The Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.; Biotech Research and Innovation Center (BRIC), University of Copenhagen, 2200 Copenhagen, Denmark.; Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.

Publikováno v: Science advances [Sci Adv] 2022 Mar 18; Vol. 8 (11), pp. eabf8627. Date of Electronic Publication: 2022 Mar 18.